It stops an enzyme that the hepatitis C virus (HCV) needs for replication
Dec 6, 2013 · SOVALDI sofosbuvir TabletsCompany: Gilead Sciences, Inc
Sep 23, 2022 · The FDA has approved Sovaldi to treat certain types of chronic (long lasting) hepatitis C virus (HCV)
Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection
Since September 2017, it has also been approved for teenagers
In December 2013, the US Food and Drug Administration (FDA) approved Sovaldi
com
Generic name: sofosbuvir Dosage form: tablet, film coated Drug class: Miscellaneous antivirals Medically reviewed by Drugs
: 204671Approval Date: 12/06/2013
SOVALDI + ribavirin ; 12 weeks : Genotype 3 ; SOVALDI + ribavirin : 24 weeks • SOVALDI in combination with ribavirin for 24 weeks can be considered for CHC patients with genotype 1 infection who are interferon ineligible
fosphenytoin will decrease the level or effect of sofosbuvir by P-glycoprotein (MDR1) efflux transporter
Avoid concomitant use
Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection
(1) • SOVALDI efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore
Common side effects may include: headache, feeling tired; anemia; nausea, loss of Generic Sovaldi Availability
Find everything you need to know about Sovaldi (Sofosbuvir), including what it is used for, warnings, reviews, side effects, and interactions
Sovaldi 400 mg; Sovaldi 200 mg; General information about the safe and effective use of Sovaldi
“The general idea is to FDA Approves Gilead's Sovaldi, First Interferon-sparing HCV Therapy
(2
There are nine patents protecting this drug and one Paragraph IV challenge